SCHEMBL7364036

SCHEMBL7364036

[CH2]Cc1ccccc1Cc1ccco1

nearest known ligand 0.49

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 3/20 0.38
KMT2A Q03164 3/20 0.38
ALDH1A1 P00352 5/20 0.38
HPGD P15428 2/20 0.38
USP2 O75604 1/20 0.38
TDP1 Q9NUW8 1/20 0.38
TSHR P16473 1/20 0.37
KDM4E B2RXH2 1/20 0.37
MAPT P10636 1/20 0.37
NPSR1 Q6W5P4 1/20 0.37
CHRM2 P08172 1/20 0.36
ALOX5 P09917 1/20 0.34
CYP3A4 P08684 1/20 0.34
ALOX15 P16050 1/20 0.34
GAA P10253 1/20 0.34
KCNH3 Q9ULD8 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17473821 0.82 KMT2A (0.41) MEN1KMT2AALDH1A1HPGDUSP2
SCHEMBL11131843 0.78 HSPA5 (0.58) MEN1KMT2ATDP1TSHRMAPT
SCHEMBL17063499 0.78 ALDH1A1 (0.48) MEN1KMT2AALDH1A1HPGDTDP1
SCHEMBL6912345 0.78 GAA (0.41) MEN1KMT2AALDH1A1HPGDTSHR
SCHEMBL28131039 0.78 TAAR1 (0.45) MEN1KMT2AALDH1A1HPGDUSP2
SCHEMBL1404275 0.77 CHRM2 (0.46) MEN1KMT2AALDH1A1HPGDUSP2
SCHEMBL30038773 0.75 ALDH1A1 (0.41) MEN1KMT2AALDH1A1HPGDUSP2
SCHEMBL8627679 0.75 NPSR1 (0.48) MEN1KMT2AALDH1A1TSHRKDM4E
SCHEMBL28546393 0.75 ALDH1A1 (0.41) MEN1KMT2AALDH1A1HPGDUSP2
SCHEMBL27593168 0.74 SLC6A2 (0.40) KMT2AALDH1A1HPGDKDM4EMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1087937-A1 CYCLIC HYDROXAMIC ACIDS AS METALLOPROTEINASE INHIBITORS Du Pont Pharmaceuticals Company (US) 2001-04-04 EP disclosed
WO-1999065867-A1 CYCLIC HYDROXAMIC ACIDS AS METALLOPROTEINASE INHIBITORS DU PONT PHARMACEUTICALS COMPANY (US) 1999-12-23 WO disclosed